Napredna pretraga

Pregled bibliografske jedinice broj: 963979

Serum C3 complement levels in ANCA associated vasculitis at diagnosis is a predictor of patient and renal outcome.


Crnogorac, Matija; Horvatić, Ivica; Kačinari, Patricia; Galešić Ljubanović, Danica; Galešić, Krešimir
Serum C3 complement levels in ANCA associated vasculitis at diagnosis is a predictor of patient and renal outcome. // JN. Journal of nephrology, 31 (2018), 2; 257-262 doi:10.1007/s40620-017-0445-3 (međunarodna recenzija, članak, stručni)


Naslov
Serum C3 complement levels in ANCA associated vasculitis at diagnosis is a predictor of patient and renal outcome.

Autori
Crnogorac, Matija ; Horvatić, Ivica ; Kačinari, Patricia ; Galešić Ljubanović, Danica ; Galešić, Krešimir

Izvornik
JN. Journal of nephrology (1121-8428) 31 (2018), 2; 257-262

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, stručni

Ključne riječi
ANCA ; Anti myeloperoxidase autoantibodies ; Anti proteinase-3 autoantibodies ; C3 factor ; Complement ; Prognostic factors ; Vasculitis

Sažetak
AIM: To determinate the prognostic significance of low serum C3 at the time of diagnosis of ANCA- associated vasculitis (AAV). METHODS: Our cohort included 75 consecutive patients with AAV diagnosed from January 2005 to December 2015. C3 levels were measured at the time of diagnosis. Patients were divided into two groups, those with low serum C3 levels (< 0.9 g/l) and those with normal serum C3 levels (0.9-1.8 g/l). We analysed association between serum C3 levels and both combined and singularly patient and renal survival (ESRD). Small number of relapsed patients did not allow for the statistical analysis to be performed as to weather the low serum C3 is associated with relapse rate in AAV patients. RESULTS: Low serum C3 levels were significantly associated with worse combined end-point patient and renal survival (HR 3.079 ; 95% CI 1.231-7.701 ; p = 0.016), and on multivariate adjusted analysis association remained significant (HR 2.831 ; 95% CI 1.093-7.338 ; p = 0.032). For both end- points individually low serum C3 levels were significantly associated with poorer patient survival (HR 6.378 ; 95% CI 2.252-18.065 ; p < 0.001 ; on multivariate adjusted analysis HR 4.315 95% CI 1.350-13.799 ; p = 0.014) and renal survival (HR 3.207 ; 95% CI 1.040-9.830 ; p = 0.043 ; on multivariate adjusted analysis HR 3.679 ; 95% CI 1.144- 11.827 ; p = 0.029). In our study there was no significant association between serological and patohistological phenotypes and serum C3 levels. CONCLUSION: Lower serum C3 levels at the diagnosis is associated with poorer patient and renal outcomes in AAV patients.

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove
Klinička bolnica "Dubrava"

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati